You just read:

Helsinn Group and MEI Pharma Announce that Pracinostat has Received Orphan Drug Designation from the European Medicines Agency for the Treatment of Acute Myeloid Leukemia (AML)

News provided by

MEI Pharma, Inc.

Jan 11, 2018, 03:00 ET